| Seattle Genetics and Bayer Partner for a Second Time to Develop Antibody-Drug Conjugates |
Abstract
|
|
Heather Cartwright |
|
| Immunocore’s ImmTAC ® Platform Gains Big Pharma Recognition with Genentech Pact |
Abstract
|
|
Heather Cartwright |
|
| Questcor Eliminates Competition for H.P Acthar® Gel with Novartis Deal |
Abstract
|
|
Heather Cartwright |
|
| Cytokinetics Gains Astellas as Partner in Field of Skeletal Muscle Activation |
Abstract
|
|
Heather Cartwright |
|
| Celgene Adds Antibody to Multiple Myeloma Pipeline with MorphoSys Deal |
Abstract
|
|
Heather Cartwright |
|
| Avanir Licenses North American Rights to OptiNose’s NDA-Ready Drug-Device Combination for Migraine |
Abstract
|
|
Heather Cartwright |
|
| J&J Gains Successor to Zytiga® with Aragon Pharmaceuticals Acquisition |
Abstract
|
|
Heather Cartwright |
|
| AstraZeneca Strengthens Core Respiratory Business with US$1.15 B Pearl Therapeutics Purchase |
Abstract
|
|
Heather Cartwright |
|
| Teva Expands Respiratory Pipeline with MicroDose Therapeutx Purchase |
Abstract
|
|
Heather Cartwright |
|
| Aspen Pharmacare Continues Global Expansion with Deal to Acquire Merck & Co. API Business |
Abstract
|
|
Heather Cartwright |
|
